BAT Tests Find Overfilled E-Cigarette Liquids in UK Market

Mar.17.2023
BAT Tests Find Overfilled E-Cigarette Liquids in UK Market
A test by BAT found most major disposable e-cigarette brands in the UK have overfilled e-liquid, according to betterRetailing.

On March 17th, UK media outlet betterRetailing released a report on BAT (British American Tobacco) testing, which revealed that almost all major disposable e-cigarette brands in the UK had exceeded the legal limit for nicotine content in their e-liquids. This included popular UK brands such as Elfbar, LOSTMARY, SMOK, SKE Crystal, and Solo. BAT sent the results of the testing report to distributors, retailers, and regulatory bodies, urging them to ensure that non-compliant products were not supplied.


The President of UKVIA, John...


In response to this incident, 2FIRSTS conducted an email interview with the President of the UK Vaping Industry Association (UKVIA), John. The original interview in English can be accessed by clicking the provided link. The following is the full transcript of the interview.


Can you provide the English translation of "Q:2FIRSTS"? It is unclear what you are referring to.


A spokesperson for the UK Vaping Industry Association (UKVIA), John


According to a report from Better Retailing, British American Tobacco conducted testing on disposable e-cigarette liquid in the UK market and sent the results to distributors and government departments. Has the association been made aware of this news? Did British American Tobacco send the testing report to the association?


BAT has conducted numerous tests on disposable e-cigarette brands in the UK and shared its findings with various organizations, including the association. It is also known that other companies have conducted similar tests, but their results differ from those of BAT.


Do you believe that the issue of "e-cigarette e-liquid exceeding standards" is a common problem in the UK e-cigarette market?


A: Yes, based on the data we have seen, we do believe that some brands have been using excessive amounts of e-liquid to gain a competitive advantage.


Question: Will this test result regarding the excessive levels found in disposable e-cigarettes have an impact on the disposable e-cigarette market in the UK?


A: Yes, I believe this highlights issues with the MHRA approval process. I expect this process to become more rigorous. Additionally, I think major distributors should now perform their own testing on products they bring in. Non-compliant behavior is unacceptable.


Several brand dealers have said that some of the products tested by BAT are "old inventory," while the latest products are now compliant with standards. Will UKVIA test the latest products?


A: The key issue is not the inventory itself, as "old stock" is not a legitimate excuse. In fact, it's quite simple - products are either compliant or non-compliant. I believe all brands should conduct regular testing to ensure they are following the rules. The association will not protect those who break the law.


Q: Has BAT been in contact with the association and asked them to take measures?


Yes, we have had multiple discussions with BAT regarding this issue. If the MHRA and trade transaction standards are the regulators and enforcers in this matter, we will work with both institutions to ensure that the products sold in the UK are legal. The association will also protect its good reputation.


Special Statement: The above content is a translated article, for accurate interpretation please refer to the original English version.


Click here to read the original article in English: UKVIA responds to overfill incident, alleging that BAT's findings contradict tests conducted by other companies.


Further reading:


Content summary of the ELFBAR over-the-limit e-liquid incident in the UK.


British media reports obtaining BAT test report: Almost all disposable e-cigarette brands in the UK have excessive e-liquid levels.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
Malaysia’s Vape Rules Face Review as Health Minister Dzulkefly Ahmad Addresses Dropped Nicotine Appeal
Malaysia’s Vape Rules Face Review as Health Minister Dzulkefly Ahmad Addresses Dropped Nicotine Appeal
According to Free Malaysia Today on August 26, 2026, Malaysia’s Health Minister Dzulkefly Ahmad said the Health Ministry would explain the government’s decision to withdraw its appeal against a High Court ruling involving the exemption of liquid nicotine used in vape products from the Poisons List. The High Court previously ruled that the exemption decision was irrational. Dzulkefly said withdrawing the appeal did not mean the government would stop regulating vaping, and that future regulatory approaches would continue under existing legal frameworks.
Aug.28
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
Philip Morris International’s IQOS has entered the Kantar BrandZ Top 100 Most Valuable Global Brands for the first time, ranking No. 74 with a brand value of $36.634 billion and becoming one of only three newcomers to the 2026 ranking. Kantar said the combined value of the Global Top 100 reached $13.1 trillion, up 22% year on year, while the threshold for entry rose to a record high. PMI says IQOS has more than 35 million users worldwide and surpassed $10 billion in annual net revenues within a decade of launch.
Sep.03
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13
Virginia Tightens Vape and Tobacco Retail Enforcement, With Fines Up to $15,000 Per Unlisted Product
Virginia Tightens Vape and Tobacco Retail Enforcement, With Fines Up to $15,000 Per Unlisted Product
A new Virginia law that took effect on July 1, 2026, requires retailers to obtain permits to sell liquid nicotine, vape and tobacco products, while directing Virginia ABC to conduct inspections and verify that stores sell only products listed in the state directory.
Jul.20
BAT UK Director Tolga Kilic Says Illicit Nicotine Market Squeezes Legal Retailers Amid Rising Compliance Costs
BAT UK Director Tolga Kilic Says Illicit Nicotine Market Squeezes Legal Retailers Amid Rising Compliance Costs
UK retail publication Grocery Trader has published a viewpoint article from Tolga Kilic, Commercial Director for BAT UK & Ireland, discussing the impact of illicit nicotine products on legitimate retail channels. Kilic said illegal vapes and other illicit nicotine products create competitive pressure for compliant retailers and called for stronger market controls and supply-chain oversight. The comments come as the UK advances policies including the disposable vape ban and Vaping Products Duty, creating a more complex operating environment for legal vape retailers.
Jul.28